Lexeo Therapeutics (LXEO) Prepaid Assets (2022 - 2026)
Lexeo Therapeutics recorded quarterly Prepaid Assets of $7.8 million in Q1 2026, up 18.02% quarter-over-quarter from $6.6 million in Q4 2025, and up 43.65% year-over-year from $5.4 million in Q1 2025.
Lexeo Therapeutics' Prepaid Assets history runs 5 years deep, the most recent figure standing at $7.8 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 43.65% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $7.8 million (up 43.65% YoY), while the FY2025 annual figure was $6.6 million, up 43.93% from the prior year.
- Prepaid Assets came in at $7.8 million for Q1 2026 at Lexeo Therapeutics, up from $6.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $7.8 million in Q1 2026 to a low of $371000.0 in Q4 2022.
- A 5-year average of $4.1 million and a median of $3.8 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 662.26% in 2023 and jumped 43.65% in 2026, its largest moves.
- Lexeo Therapeutics' Prepaid Assets stood at $371000.0 in 2022, then soared by 662.26% to $2.8 million in 2023, then surged by 62.77% to $4.6 million in 2024, then soared by 43.93% to $6.6 million in 2025, then climbed by 18.02% to $7.8 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $7.8 million, $6.6 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.82 Mn |
| Dec 31, 2025 | 6.63 Mn |
| Sep 30, 2025 | 5.03 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | 5.44 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Dec 31, 2022 | 371,000.00 |